Your PNH specialist may be able to refer you to ... or you can use the American Psychological Association’s psychologist locator service to find a therapist in your area. You can also visit ...

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired, potentially life-threatening disorder linked to a specific gene. It can occur at any age but most often is diagnosed in young adults.

Paroxysmal nocturnal hemoglobinuria (PNH) happens when your immune system attacks your red blood cells and platelets. If not treated, it can lead to complications that include blood clots ...

Novartis has unveiled further data for Fabhalta (iptacopan), reinforcing its position in the paroxysmal nocturnal ...

"We are working with the [National PNH Service] to incorporate PiaSky into the patient pathway and we remain committed to ensuring that this treatment is available across the rest of the UK as ...

The latest positive readout comes from the APPLY-PNH study, which pitted iptacopan against AstraZeneca/Alexion's anti-C5 antibodies Soliris (eculizumab) and Ultomiris (ravulizumab) in adults with ...

Ilene Weitz, MD, details a few abstracts on paroxysmal nocturnal hemoglobinuria (PNH) treatments that will be presented at ASH 2024, particularly data on danicopan as an add-on to ravulizumab or ...

Alexis Lorenze was diagnosed with Paroxysmal Nocturnal Hemoglobinuria (PNH) in January. The extremely rare condition affects approximately one in a million people, causing the immune system to ...

Please provide your email address to receive an email when new articles are posted on . Ravulizumab led to maintained control of intravascular hemolysis and sustained stable hemoglobin levels ...